AND-1是R循环动态的关键调节器,也是克服内分泌抵抗的目标
Zhuqing Li1,2, Yihan Peng3, Huai-Chin Chiang1
1Department of Biochemistry and Molecular Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Science advances
|August 6, 2025
概括
DNA结合蛋白AND-1调节DNA/RNA混合体 (R环),对基因组稳定性至关重要. 乳腺癌细胞中AND-1抑制提供了一种针对内分泌抵抗的新策略.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- R-循环 (DNA/RNA混合体) 对于细胞功能至关重要,但在失调时与基因组不稳定性和疾病有关.
- RNase H1 是一种关键的酶,它可以分解R循环,保持基因组的完整性.
研究的目的:
- 为了确定R-循环动态的新型调节器.
- 研究AND-1在R循环解析中的作用及其在乳腺癌中的治疗潜力.
主要方法:
- 确定AND-1是一种与R循环结构相互作用的DNA结合蛋白.
- 通过AND-1评估RNase H1的招募和内核酶活性增强.
- 在缺少AND-1的小鼠乳腺组织中分析了R-循环积累.
- 研究了AND-1抑制对ER+乳腺癌细胞ESR1表达的影响.
主要成果:
- AND-1直接与R循环结合,增强RNase H1的招募和活动.
- 缺少AND-1会导致R循环在体内积聚.
- AND-1抑制通过破坏ESR1增强器的R循环调节来降低ESR1表达.
- 这种机制克服了ER+乳腺癌细胞中的芳酶抑制剂耐药性.
结论:
- AND-1是R循环动态的一个关键调节器.
- AND-1调制代表了对内分泌抵抗性乳腺癌的潜在治疗策略.
相关概念视频
Negative Regulator Molecules
36.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K
Target Cell Response to Hormones
3.5K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Feedback Loops
58.6K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
58.6K


